nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0835	0.383	CbGeAlD
Ketorolac—PTGS2—Nicotinate metabolism—NMNAT3—polycystic ovary syndrome	0.0341	0.113	CbGpPWpGaD
Ketorolac—Azotaemia—Metformin—polycystic ovary syndrome	0.0249	0.0519	CcSEcCtD
Ketorolac—PTGS2—Nicotinamide salvaging—NAMPT—polycystic ovary syndrome	0.0213	0.0703	CbGpPWpGaD
Ketorolac—Heartburn—Metformin—polycystic ovary syndrome	0.0193	0.0402	CcSEcCtD
Ketorolac—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0164	0.0341	CcSEcCtD
Ketorolac—Blood disorder—Metformin—polycystic ovary syndrome	0.0159	0.0331	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0128	0.0424	CbGpPWpGaD
Ketorolac—Lightheadedness—Metformin—polycystic ovary syndrome	0.0119	0.0247	CcSEcCtD
Ketorolac—PTGS2—Nicotinate metabolism—NAMPT—polycystic ovary syndrome	0.0113	0.0374	CbGpPWpGaD
Ketorolac—PTGS2—embryo—polycystic ovary syndrome	0.0113	0.0518	CbGeAlD
Ketorolac—Ear pain—Metformin—polycystic ovary syndrome	0.0113	0.0235	CcSEcCtD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.011	0.0362	CbGpPWpGaD
Ketorolac—Injury—Metformin—polycystic ovary syndrome	0.0105	0.0218	CcSEcCtD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0102	0.0337	CbGpPWpGaD
Ketorolac—Renal impairment—Metformin—polycystic ovary syndrome	0.0101	0.0211	CcSEcCtD
Ketorolac—Migraine—Metformin—polycystic ovary syndrome	0.00948	0.0198	CcSEcCtD
Ketorolac—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00925	0.0424	CbGeAlD
Ketorolac—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00889	0.0185	CcSEcCtD
Ketorolac—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00879	0.0183	CcSEcCtD
Ketorolac—Breast disorder—Metformin—polycystic ovary syndrome	0.0087	0.0181	CcSEcCtD
Ketorolac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.0087	0.0288	CbGpPWpGaD
Ketorolac—PTGS1—endometrium—polycystic ovary syndrome	0.00864	0.0396	CbGeAlD
Ketorolac—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00861	0.0179	CcSEcCtD
Ketorolac—Abdominal distension—Metformin—polycystic ovary syndrome	0.00838	0.0175	CcSEcCtD
Ketorolac—PTGS2—endometrium—polycystic ovary syndrome	0.00826	0.0379	CbGeAlD
Ketorolac—Pancreatitis—Metformin—polycystic ovary syndrome	0.00816	0.017	CcSEcCtD
Ketorolac—Sweating increased—Metformin—polycystic ovary syndrome	0.00811	0.0169	CcSEcCtD
Ketorolac—PTGS1—uterus—polycystic ovary syndrome	0.00796	0.0365	CbGeAlD
Ketorolac—PTGS1—pituitary gland—polycystic ovary syndrome	0.00782	0.0359	CbGeAlD
Ketorolac—PTGS1—adipose tissue—polycystic ovary syndrome	0.00779	0.0357	CbGeAlD
Ketorolac—PTGS2—uterus—polycystic ovary syndrome	0.00761	0.0349	CbGeAlD
Ketorolac—PTGS2—pituitary gland—polycystic ovary syndrome	0.00747	0.0343	CbGeAlD
Ketorolac—PTGS2—adipose tissue—polycystic ovary syndrome	0.00744	0.0342	CbGeAlD
Ketorolac—Drowsiness—Metformin—polycystic ovary syndrome	0.00742	0.0155	CcSEcCtD
Ketorolac—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00702	0.0146	CcSEcCtD
Ketorolac—PTGS1—adrenal gland—polycystic ovary syndrome	0.00698	0.0321	CbGeAlD
Ketorolac—Bradycardia—Metformin—polycystic ovary syndrome	0.00678	0.0141	CcSEcCtD
Ketorolac—Rhinitis—Metformin—polycystic ovary syndrome	0.00668	0.0139	CcSEcCtD
Ketorolac—PTGS2—adrenal gland—polycystic ovary syndrome	0.00668	0.0306	CbGeAlD
Ketorolac—Hepatitis—Metformin—polycystic ovary syndrome	0.00666	0.0139	CcSEcCtD
Ketorolac—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00654	0.0136	CcSEcCtD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.00651	0.0215	CbGpPWpGaD
Ketorolac—PTGS1—female gonad—polycystic ovary syndrome	0.00651	0.0299	CbGeAlD
Ketorolac—PTGS1—vagina—polycystic ovary syndrome	0.00647	0.0297	CbGeAlD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00631	0.0208	CbGpPWpGaD
Ketorolac—PTGS2—female gonad—polycystic ovary syndrome	0.00622	0.0286	CbGeAlD
Ketorolac—Eye disorder—Metformin—polycystic ovary syndrome	0.00622	0.013	CcSEcCtD
Ketorolac—PTGS2—vagina—polycystic ovary syndrome	0.00619	0.0284	CbGeAlD
Ketorolac—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00618	0.0129	CcSEcCtD
Ketorolac—Flushing—Metformin—polycystic ovary syndrome	0.00618	0.0129	CcSEcCtD
Ketorolac—PTGS1—endocrine gland—polycystic ovary syndrome	0.00606	0.0278	CbGeAlD
Ketorolac—Angiopathy—Metformin—polycystic ovary syndrome	0.00604	0.0126	CcSEcCtD
Ketorolac—Immune system disorder—Metformin—polycystic ovary syndrome	0.00602	0.0125	CcSEcCtD
Ketorolac—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.006	0.0125	CcSEcCtD
Ketorolac—Chills—Metformin—polycystic ovary syndrome	0.00598	0.0125	CcSEcCtD
Ketorolac—Malnutrition—Metformin—polycystic ovary syndrome	0.0058	0.0121	CcSEcCtD
Ketorolac—Erythema—Metformin—polycystic ovary syndrome	0.0058	0.0121	CcSEcCtD
Ketorolac—PTGS2—endocrine gland—polycystic ovary syndrome	0.00579	0.0266	CbGeAlD
Ketorolac—Flatulence—Metformin—polycystic ovary syndrome	0.00571	0.0119	CcSEcCtD
Ketorolac—Dysgeusia—Metformin—polycystic ovary syndrome	0.00568	0.0118	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00554	0.0183	CbGpPWpGaD
Ketorolac—Vision blurred—Metformin—polycystic ovary syndrome	0.00546	0.0114	CcSEcCtD
Ketorolac—Tremor—Metformin—polycystic ovary syndrome	0.00543	0.0113	CcSEcCtD
Ketorolac—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00538	0.0112	CcSEcCtD
Ketorolac—Malaise—Metformin—polycystic ovary syndrome	0.00523	0.0109	CcSEcCtD
Ketorolac—Syncope—Metformin—polycystic ovary syndrome	0.0052	0.0108	CcSEcCtD
Ketorolac—Palpitations—Metformin—polycystic ovary syndrome	0.00512	0.0107	CcSEcCtD
Ketorolac—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0051	0.0106	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.00508	0.0168	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00501	0.0165	CbGpPWpGaD
Ketorolac—Hypertension—Metformin—polycystic ovary syndrome	0.00501	0.0104	CcSEcCtD
Ketorolac—Myalgia—Metformin—polycystic ovary syndrome	0.00494	0.0103	CcSEcCtD
Ketorolac—Chest pain—Metformin—polycystic ovary syndrome	0.00494	0.0103	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0049	0.0102	CcSEcCtD
Ketorolac—Discomfort—Metformin—polycystic ovary syndrome	0.00488	0.0102	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00478	0.0158	CbGpPWpGaD
Ketorolac—Oedema—Metformin—polycystic ovary syndrome	0.00473	0.00987	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00471	0.0156	CbGpPWpGaD
Ketorolac—Infection—Metformin—polycystic ovary syndrome	0.0047	0.0098	CcSEcCtD
Ketorolac—Shock—Metformin—polycystic ovary syndrome	0.00466	0.00971	CcSEcCtD
Ketorolac—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00464	0.00968	CcSEcCtD
Ketorolac—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00463	0.00966	CcSEcCtD
Ketorolac—Skin disorder—Metformin—polycystic ovary syndrome	0.0046	0.00958	CcSEcCtD
Ketorolac—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00457	0.00954	CcSEcCtD
Ketorolac—Anorexia—Metformin—polycystic ovary syndrome	0.00451	0.0094	CcSEcCtD
Ketorolac—Hypotension—Metformin—polycystic ovary syndrome	0.00442	0.00922	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.0044	0.0145	CbGpPWpGaD
Ketorolac—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00431	0.00899	CcSEcCtD
Ketorolac—Paraesthesia—Metformin—polycystic ovary syndrome	0.00425	0.00886	CcSEcCtD
Ketorolac—Dyspnoea—Metformin—polycystic ovary syndrome	0.00422	0.0088	CcSEcCtD
Ketorolac—Somnolence—Metformin—polycystic ovary syndrome	0.00421	0.00877	CcSEcCtD
Ketorolac—Dyspepsia—Metformin—polycystic ovary syndrome	0.00417	0.00868	CcSEcCtD
Ketorolac—Decreased appetite—Metformin—polycystic ovary syndrome	0.00411	0.00858	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00408	0.00852	CcSEcCtD
Ketorolac—Fatigue—Metformin—polycystic ovary syndrome	0.00408	0.00851	CcSEcCtD
Ketorolac—Constipation—Metformin—polycystic ovary syndrome	0.00405	0.00844	CcSEcCtD
Ketorolac—PTGS1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00396	0.0131	CbGpPWpGaD
Ketorolac—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0039	0.00813	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—polycystic ovary syndrome	0.00389	0.0129	CbGpPWpGaD
Ketorolac—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00387	0.00807	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00379	0.0125	CbGpPWpGaD
Ketorolac—Urticaria—Metformin—polycystic ovary syndrome	0.00376	0.00784	CcSEcCtD
Ketorolac—Abdominal pain—Metformin—polycystic ovary syndrome	0.00374	0.0078	CcSEcCtD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00374	0.0124	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.00361	0.0119	CbGpPWpGaD
Ketorolac—Asthenia—Metformin—polycystic ovary syndrome	0.00339	0.00708	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00337	0.0112	CbGpPWpGaD
Ketorolac—Pruritus—Metformin—polycystic ovary syndrome	0.00335	0.00698	CcSEcCtD
Ketorolac—Diarrhoea—Metformin—polycystic ovary syndrome	0.00324	0.00675	CcSEcCtD
Ketorolac—PTGS2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00314	0.0104	CbGpPWpGaD
Ketorolac—Dizziness—Metformin—polycystic ovary syndrome	0.00313	0.00652	CcSEcCtD
Ketorolac—Vomiting—Metformin—polycystic ovary syndrome	0.00301	0.00627	CcSEcCtD
Ketorolac—Rash—Metformin—polycystic ovary syndrome	0.00298	0.00622	CcSEcCtD
Ketorolac—Dermatitis—Metformin—polycystic ovary syndrome	0.00298	0.00621	CcSEcCtD
Ketorolac—Headache—Metformin—polycystic ovary syndrome	0.00296	0.00618	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00294	0.00971	CbGpPWpGaD
Ketorolac—Nausea—Metformin—polycystic ovary syndrome	0.00281	0.00586	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00273	0.00902	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00268	0.00885	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00265	0.00876	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00248	0.00821	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.0023	0.0076	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00228	0.00754	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00216	0.00715	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00216	0.00714	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00211	0.00697	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.0021	0.00695	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.002	0.00662	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00197	0.00652	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00182	0.00602	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00181	0.00599	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00176	0.00582	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00175	0.00577	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00174	0.00576	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00167	0.00552	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00165	0.00547	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00156	0.00516	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00151	0.005	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00149	0.00493	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00147	0.00487	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00145	0.00479	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.0014	0.00464	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00139	0.00458	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00137	0.00454	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00133	0.00438	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00132	0.00437	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00132	0.00437	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.0013	0.00429	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00126	0.00417	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00118	0.0039	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00117	0.00388	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00117	0.00387	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00115	0.00379	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00111	0.00368	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00111	0.00366	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00108	0.00356	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00105	0.00347	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00105	0.00347	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00105	0.00347	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00105	0.00346	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.001	0.00331	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000988	0.00327	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000931	0.00308	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000925	0.00306	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000879	0.0029	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000861	0.00285	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000855	0.00283	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000851	0.00281	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000833	0.00275	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000815	0.0027	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000815	0.00269	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000813	0.00269	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000795	0.00263	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000776	0.00257	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000771	0.00255	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000759	0.00251	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000744	0.00246	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000744	0.00246	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000735	0.00243	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000694	0.00229	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000692	0.00229	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.00069	0.00228	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000676	0.00224	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000676	0.00223	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000646	0.00213	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000631	0.00209	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000616	0.00204	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000602	0.00199	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000599	0.00198	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000591	0.00195	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000591	0.00195	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000588	0.00194	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000588	0.00194	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000583	0.00193	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000566	0.00187	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000557	0.00184	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000549	0.00182	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000537	0.00177	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000512	0.00169	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000501	0.00166	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000493	0.00163	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000484	0.0016	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000475	0.00157	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000467	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000467	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000467	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000449	0.00148	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000446	0.00147	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000442	0.00146	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000441	0.00146	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000423	0.0014	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000407	0.00134	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000397	0.00131	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000397	0.00131	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000391	0.00129	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000379	0.00125	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000377	0.00124	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000375	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000371	0.00123	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000355	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000354	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00035	0.00116	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000346	0.00114	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000338	0.00112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000327	0.00108	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000322	0.00106	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000316	0.00105	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000315	0.00104	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.00031	0.00103	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000301	0.000995	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000301	0.000995	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000297	0.000983	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000292	0.000964	CbGpPWpGaD
Ketorolac—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000288	0.000951	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000285	0.000944	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000282	0.000932	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000281	0.000929	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000274	0.000907	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.00027	0.000893	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000268	0.000888	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000268	0.000887	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000267	0.000882	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000265	0.000875	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000263	0.000869	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.00026	0.000859	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000256	0.000846	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000252	0.000833	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000248	0.00082	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000239	0.00079	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000239	0.000789	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000235	0.000777	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000231	0.000765	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000223	0.000738	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000215	0.000709	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000214	0.000709	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000213	0.000705	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000212	0.0007	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00021	0.000695	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000209	0.00069	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000201	0.000665	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.0002	0.000661	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000198	0.000654	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000197	0.000651	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000196	0.000649	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000189	0.000624	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000175	0.000579	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.00017	0.000563	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000167	0.000552	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000166	0.000548	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000158	0.000523	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000158	0.000523	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000156	0.000515	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000155	0.000513	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000147	0.000487	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.00014	0.000462	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000139	0.00046	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.000133	0.00044	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.000132	0.000438	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000126	0.000415	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.00012	0.000395	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000118	0.00039	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.000117	0.000388	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	0.000117	0.000387	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IRS1—polycystic ovary syndrome	0.000116	0.000384	CbGpPWpGaD
Ketorolac—PTGS2—Disease—INS—polycystic ovary syndrome	0.000111	0.000367	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT2—polycystic ovary syndrome	0.000107	0.000355	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	0.000102	0.000338	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	9.49e-05	0.000314	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—POMC—polycystic ovary syndrome	9.36e-05	0.000309	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—INS—polycystic ovary syndrome	9.31e-05	0.000308	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—polycystic ovary syndrome	4.86e-05	0.000161	CbGpPWpGaD
